Stabilization of metastable flufenamic acid by inclusion of mefenamic acid: Solid solution or epilayer?

Journal of Pharmaceutical Sciences

Volumn 99, Issue 9, 2010, Pages 4013-4022

  Lee, Eun Hee ^a   Byrn, Stephen R ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Epilayer; Flufenamic acid; Inclusion compound; Mefenamic acid; Solid solution; Solid state polymorphic transformation

Indexed keywords

FLUFENAMIC ACID; MEFENAMIC ACID;

ARTICLE; CRYSTAL; CRYSTALLIZATION; DRUG FORMULATION; DRUG STABILITY; SOLID STATE; SOLUTION AND SOLUBILITY; SURFACE PROPERTY;

EID: 77956385390     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22250     Document Type: Article

References (29)

1. Byrn SR, Pfeiffer RR, Stowell JG. 1999. Solid-state chemistry of drugs. 2nd edition. West Lafayette: SSCI, Inc. p 259.
2. Ostwald WZ. 1897. Studien über die Bildung und Umwandlung fester Körper. 1. Abhandlung: Berstattigung und Begrundlung. Z Phys Chem 22:289-330.
3. Weissbuch I, Lahav M, Leiserowitz L. 2003. Toward stereo-chemical control, monitoring, and understanding of crystal nucleation. Cryst Growth Des 3:125-150.
4. Bauer J, Spanton S, Henry R, Quick J, Dziki W, Porter W, Morris J. 2001. Ratinovir: An extraordinary example of conformational polymorphism. Pharm Res 18:859-866. (Pubitemid 32783524)
5. Aguiar AJ, Zelmer JE. 1969. Dissolution behavior of polymorphs of chloramphenicol palmitate and mefenamic acid. J Pharm Sci 58:983-987.
6. Paul IC, Curtin DY. 1973. Thermally induced organic reactions in the solid state. Acc Chem Res 6:217-225.
7. Mukuta T, Lee AY, Kawakami T, Myerson AS. 2005. Influence of impurities on the solution-mediate phase transformation of an active pharmaceutical ingredient. Cryst Growth Des 5:1429-1436.
8. Gu C-H, Chatterjee K, Young V, Jr., Grant DJW. 2002. Stabilization of a metastable polymorph of sulfamerazine by structurally related additives. J Cryst Growth 235:471-481.
9. Ferrari ES, Davey RJ. 2001. Solution-mediated transformation of α to β L-glutamic acid: Rate enhancement due to secondary nucleation. Cryst Growth Des 4:1061-1068.
10. Blagden N, Davey RJ, Rowe R, Roberts R. 1998. Disappearing polymorphs and the role of reaction byproducts: The case of sulphathiazole. Int J Pharm 172:169-177.
11. Davey RJ, Blagden N, Potts GD, Docherty R. 1997. Polymorphism in molecular crystals: Stabilization of a metastable form by conformational mimicry. J Am Chem Soc 119:1767-1772. (Pubitemid 27145524)
12. Davey RJ, Maginn SJ, Andrews SJ, Buckley AM, Cottier D, Dempsey P, Rout JE, Stanley DR, Taylor A. 1993. Stabilization of a metastable crystalline phase by twinning. Nature 366:248-250.
13. He X, Stowell JG, Morris KR, Pfeiffer RR, Li H, Patrick Stahly G, Byrn SR. 2001. Stabilization of a metastable polymorph of 4-methyl-2-nitroacetanilide by isomorphic additives. Cryst Growth Des 1:305-312.
14. Kitaigorodsky AI. 1984. Mixed crystals. Berlin Heidelberg, New York: Springer-Verlag. pp 26-40.
15. Godqik G, Pfnur H, Lyuksyutov IF. 2001. Impurity-induced changes of overlayer symmetry and of phase transitions. Europhys Lett 56:67-73. (Pubitemid 33398303)
16. Dekoster J, Jedryka E, Meny C, Langouche G. 1993. Epilayer-induced structural transition to b.c.c. Co during epitaxial growth of Co/Fe superlattices. Europhys Lett 22:433-438.
17. Burger A, Ramberger R. 1980. Thermodynamische beziehungen zwischen polymorphen modifikationen: Flufenaminsaure und mefenaminsaure. Mikrochim Acta 73:17-28.
18. McCrone WC. 1965. Polymorphism. In: Fox D, Labes MM, Weissberger A, editors. Physics and chemistry of the organic solid state. New York: John Wiley & Sons. pp 725-767.
19. Mullin JW. 2001. Crystallization. 4th edition. Oxford, Burlington: Elsevier Butterworth-Heinemann. pp 154-155, 181-215.
20. Lee EH, Byrn SR, Carvajal MT. 2006. Additive-induced metastable single crystal of mefenamic acid. Pharm Res 23:2375-2380.
21. Cabrera N, Vermilyea DA. 1958. The growth of crystals from solution. In: Doremus RH, Roberts BW, Turnbull D, editors. Growth and perfection of crystals. New York: John Wiley & Sons, Inc. pp 393-410.
22. Hendriksen BA, Grant DJW. 1995. The effect of structurally related substances on the nucleation kinetics of paracetamol (acetaminophen). J Cryst Growth 156:252-260.
23. Michaels AS, Tausch FW, Jr. 1961. Modification of growth rate and habit of adipic acid crystals with surfactants. J Phys Chem 65:1730-1737.
24. Sears GW. 1958. The effect of poisons on crystal growth. In: Doremus RH, Roberts BW, Turnbull D, editors. Growth and perfection of crystals. New York: John Wiley & Sons, Inc. pp 441-445.
25. Lee EH, Boerrigter SXM, Byrn SR. 2010. Epitaxy of a structurally related compound on the (100) faces of flufenamic acid form I and III single crystals. Cryst Growth Des 10:518-527.
26. Chikazumi S. 1950. Ferromagnetic properties and superlattice formation of iron nickel alloys (I). J Phys Soc Jpn 5:327-333.
27. Iwata T. 1995. A statistical theory of the anisotropic distribution of atom pairs in binary alloys. J Jpn I Met 19:95-99.
28. Kitaigorodsky AI. 1973. Conditions for formation of solid solution. In: Loebl EM, editor. Molecular crystals and molecules. New York, London: Academic Press, Inc. pp 94-105.
29. 2 mefenamic acid. Cryst Struct Comm 5:861-864.